ArticleCurrent oncology (Toronto, Ont.)2025

Combination of Osimertinib and Brigatinib in the Treatment of EGFR Triple-Mutated Lung Adenocarcinoma: A Case Report.

Daphnée Demers et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.